Abstract
Soft-tissue sarcomas are a rare and heterogeneous group of tumors. The last few decades have seen rapid strides in surgery with function preserving alternatives for local control in these lesions becoming the norm without compromising on overall disease survival. Good functional and oncological results can be achieved with a combination of excision of the tumor, and where required, suitable adjuvant therapies. These lesions are best managed at specialty centres where the requisite multidisciplinary care can be offered to the patient to optimise results. This overview is intended as a review of current understanding and the multimodality management of these challenging tumors.
Similar content being viewed by others
References
Kasper B, Gil T, D’Hondt V, Gebhart M, Awada A. Novel treatment strategies for soft tissue sarcoma. Crit Rev Oncol Hematol 2007;62:9–15.
Jansen-Landheer ML, Krijnen P, Oostindier MJ, Kloosterman-Boele WM, Noordijk EM, Nooij MA, et al. Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study. Eur J Surg Oncol 2009;35:1326–32.
Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma 2010;2010:506182.
National Cancer Institute: Adult Soft Tissue Sarcoma Treatment (PDQ®) 2011. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/Health Professional [updated on 24 Jan 2011].
Narvani AA, Tsiridis E, Saifuddin A, Briggs T, Cannon S. Does image guidance improve accuracy of core needle biopsy in diagnosis of soft tissue tumours? Acta Orthop Belg 2009;75:239–44.
Heslin MJ, Lewis JJ, Woodruff JM, Brennan MF. Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol 1997;4:425–31.
Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20(Suppl 4):132–6.
Pollock RC, Stalley PD. Biopsy of musculoskeletal tumours—beware. ANZ J Surg 2004;74:516–9.
Daugaard S. Current soft-tissue sarcoma classifications. Eur J Cancer 2004;40:543–8.
Cormier JN, Huang X, Xing Y, Thall PF, Wang X, Benjamin RS, et al. Cohort analysis of patients with localized, highrisk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 2004;22:4567–74.
Christie-Large M, James SL, Tiessen L, Davies AM, Grimer RJ. Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas. Eur J Cancer 2008;44:1841–5.
Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults: Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993;217:72–7.
Okazumi S, Dimitrakopoulou-Strauss A, Schwarzbach MH, Strauss LG. Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: Relation to differential diagnosis, tumor grading and prediction of prognosis. Hell J Nucl Med 2009;12:223–8.
Vraa S, Keller J, Nielsen OS, Sneppen O, Jurik AG, Jensen OM. Prognostic factors in soft tissue sarcomas: The Aarhus experience. Eur J Cancer 1998;34:1876–82.
Bhangu AA, Beard JA, Grimer RJ. Should soft tissue sarcomas be treated at a specialist centre? Sarcoma 2004;8:1–6.
Abellan JF, Lamo de Espinosa JM, Duart J, Patino-Garcia A, Martin-Algarra S, Martinez-Monge R, et al. Nonreferral of possible soft tissue sarcomas in adults: A dangerous omission in policy. Sarcoma 2009;2009:827912.
Watson DI, Coventry BJ, Langlois SL, Gill PG. Soft-tissue sarcoma of the extremity: Experience with limb-sparing surgery. Med J Aust 1994;160:412–6.
Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;153:106–20.
Novais EN, Demiralp B, Alderete J, Larson MC, Rose PS, Sim FH. Do surgical margin and local recurrence influence survival in soft tissue sarcomas? Clin Orthop Relat Res 2010;468:3003–11.
Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 2004;429:165–72.
Manoso MW, Frassica DA, Deune EG, Frassica FJ. Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas. J Surg Oncol 2005;91:153–8.
O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet 2002;359:2235–41.
Robinson MH, Ball AB, Schofield J, Fisher C, Harmer CL, Thomas JM. Preoperative radiotherapy for initially inoperable extremity soft tissue sarcomas. Clin Oncol (R Coll Radiol) 1992;4:36–43.
Laskar S, Bahl G, Puri A, Agarwal MG, Muckaden M, Patil N, et al. Perioperative interstitial brachytherapy for soft tissue sarcomas: Prognostic factors and long-term results of 155 patients. Ann Surg Oncol 2007;14:560–7.
Stewart AJ, Lee YK, Saran FH. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for postoperative radiotherapy for primary extremity soft tissue sarcoma. Radiother Oncol 2009;93:125–30.
Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Cochrane Database Syst Rev 2000;4:CD001419.
Cool P, Grimer R, Rees R. Surveillance in patients with sarcoma of the extremities. Eur J Surg Oncol 2005;31:1020–4.
Alexander J, Haight C. Pulmonary resection for solitary metastatic sarcomas and carcinomas. Surg Gynecol Obstet 1947;85:129–46.
Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196:305–15.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Puri, A., Gulia, A. Management of extremity soft tissue sarcomas. IJOO 45, 301–306 (2011). https://doi.org/10.4103/0019-5413.82332
Published:
Issue Date:
DOI: https://doi.org/10.4103/0019-5413.82332